Position in VYGR
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$222,204
-$9,355 QoQ
Shares Held
57,566
-2.3% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,289,073 across 287 Biotechnology names. VYGR ranks #197 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in VYGR
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $222,204 | 57,566 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $231,559 | 58,921 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $326,857 | 69,991 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $212,372 | 68,287 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $229,762 | 67,977 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $405,387 | 71,497 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $404,486 | 69,143 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $573,166 | 72,461 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $432,421 | 46,447 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $360,691 | 42,736 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $333,560 | 43,040 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $474,155 | 41,411 | Shares | Sole | 2023-08-08 | |
| 2021-03-31 | $159,518 | 33,868 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $251,451 | 35,168 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $342,165 | 32,068 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $467,104 | 37,013 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $307,046 | 33,557 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||